dsRNA compositions and methods for treating HPV infections

Details for Australian Patent Application No. 2008231816 (hide)

Owner Novartis AG

Inventors Vornlocher, Hans-Peter; Fitzgerald, Kevin; Bramlage, Birgit; Benson, John; Tan, Pamela

Agent FB Rice

Pub. Number AU-A-2008231816

PCT Pub. Number WO2008/116860

Priority 60/908,098 26.03.07 US

Filing date 25 March 2008

Wipo publication date 2 October 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/116860 Priority application(s): WO2008/116860

11 February 2010 Assignment before Grant

  Novartis AG The application has been assigned to Alnylam Pharmaceuticals, Inc.

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231823-Foamy compositions

2008231797-An ergonomic monitor support device